Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Chronic Cough Clinical Trials

A listing of Chronic Cough medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (7) clinical trials

This study is testing an investigational medication for adults with chronic cough

Phase

A double-blind, randomized, placebo-controlled study of the efficacy and safety of three doses of Orvepitant in subjects with chronic refractory cough.

Phase

The purpose of this study is to determine the effectiveness of three doses of orvepitant, taken once a day, in the treatment of chronic refractory cough.

Phase

Summary: A clinical research study for an investigational medication for Chronic Cough. www.dxrg.com

Phase

A Dose-ranging Study of Orvepitant in Patients With Chronic Refractory Cough

A multi-center, double-blind, randomized, parallel group, placebo-controlled dose range study in subjects with chronic refractory cough (CRC). Doses of orvepitant (10 mg/day, 20 mg/day and 30 mg/day) and placebo will be investigated in four parallel groups. Each group will compromise of approximately 61 subjects, randomized 1:1:1:1 (approximately 244 subjects in ...

Phase

Pilot of Zinc Acetate to Improve Chronic Cough

Chronic refractory cough in adults is defined as a cough lasting more than 8 weeks that does not resolve with treatment for asthma/eosinophilic airway disease, gastroesophageal reflux disease (GERD), or rhinosinusitis/post-nasal drip; and is not caused by smoking, angiotensin-converting-enzyme (ACE) inhibitors, or parenchymal lung disease. This is one of the ...

Phase

A Study to Assess the Effectiveness and Side Effects of GSK2798745 in Participants With Chronic Cough

GSK2798745 is a potent and selective transient receptor potential vanilloid 4 (TRPV4) channel blocker being investigated for the treatment of chronic cough. This is a multi-center, randomized, placebo-controlled, double-blind, two-period crossover study with a purpose to evaluate efficacy and safety of GSK2798745. Each subject will have 2 treatment periods, and ...

Phase